Opportunity

Simpler Grants.gov #PAR-27-007

NIH Forecast: Clinical Trials and Ancillary Studies within NIH-Funded Clinical Trial Research Networks (UG3/UH3)

Buyer

National Institutes of Health

Posted

October 04, 2023

Respond By

November 10, 2026

Identifier

PAR-27-007

NAICS

541715

This opportunity is a forecasted research grant from the National Institutes of Health (NIH), led by the National Institute of Neurological Disorders and Stroke (NINDS) in partnership with other NIH Institutes and Centers. - The program supports clinical trials and ancillary studies within NIH-funded Clinical Trial Research Networks - Structure: Two-phase (UG3/UH3 cooperative agreement) - Phase 1: Planning and start-up (up to 2 years) - Phase 2: Implementation (up to 5 additional years, contingent on milestones) - No specific products, part numbers, or purchase quantities are listed, as this is a research funding opportunity - No OEMs or vendors are specified - The notice is intended to give applicants time to develop collaborations and projects - Eligible applicants include government entities, nonprofits, educational institutions, businesses, and tribal organizations

Description

The National Institute of Neurological Disorders and Stroke (NINDS), along with other NIH Institutes and Centers, seeks to support projects proposing clinical trials and ancillary studies within NIH-funded Clinical Trial Research Networks. The program encourages multi-center clinical trials within established NIH-funded networks, using a bi-phasic, milestone-driven UG3/UH3 cooperative agreement. Awards initially support a 2-year planning and start-up phase, with possible transition to a 5-year implementation phase. Applications are not currently being solicited; this notice provides time for potential applicants to develop collaborations and projects.

View original listing